Urology treats urinary tract diseases in all genders and male reproductive issues, covering the kidneys, bladder, prostate, urethra, from infections to complex cancers.
Send us all your questions or requests, and our expert team will assist you.
Ureteral stones, also called ureterolithiasis, are a specific and often very painful type of urinary tract stone. Although people often group them with kidney stones, ureteral stones are different because of where they are located and the urgent problems they cause. These stones are made of minerals and acid salts that form in the kidney’s collecting system and then move into the ureter. The ureter is a muscular tube about 25 to 30 centimeters long that carries urine from the kidney to the bladder.
When a stone moves from the wide renal pelvis into the narrow ureter, it goes from being silent to causing a sudden blockage. This condition is defined by the mechanical blockage of urine flow. The ureter is not just a passive tube; it actively contracts in waves to push urine along. When a stone blocks the way, the ureter contracts even harder to try to push it out. These strong contractions, along with the buildup of urine pressure, stretch the kidney and ureter walls, which explains the pain and symptoms of this condition.
On a cellular level, a ureteral stone sets off a series of changes. The lining of the ureter, called the urothelium, is damaged by the stone and by pressure. The blockage also sends pressure back to the kidney, causing it to swell (hydronephrosis). This pressure squeezes the small blood vessels in the kidney and changes how blood flows there. At first, the body tries to increase blood flow to clear the blockage, but if the blockage lasts, the blood vessels narrow to protect the kidney. So, ureterolithiasis is more than just a stone in a tube—it is a complex reaction between the stone and the body’s efforts to protect the kidney.
To understand ureteral stones, it helps to look at how they form, a process called lithogenesis. Stones do not start in the ureter; they come from the kidney. The process begins when urine becomes supersaturated, meaning it contains more stone-forming salts like calcium, oxalate, and uric acid than it can hold in solution. Normally, these substances stay dissolved, but when their levels get too high, crystals can start to form.
This state acts as the catalyst for nucleation, the birth of a crystal. Microscopic crystals form and, in the absence of adequate inhibitors like citrate or magnesium, aggregate into larger, organized structures. This aggregation is not merely a random clumping but a structured biological mineralization process, often forming on a specific anchor point within the kidney tissue, such as a Randall’s plaque (a calcium phosphate deposit on the renal papillae). Once the aggregate grows sufficiently large, it detaches and enters the collecting system.
The biological composition of the stone dictates its behavior and response to treatment.
A stone’s path through the ureter is difficult because the ureter is not the same width throughout. There are three main narrow spots where stones often get stuck. Knowing about these narrow points helps doctors understand symptoms and plan treatment.
Doctors classify ureteral obstruction as either partial or complete. A partial blockage lets some urine through, causing occasional pain and slower kidney damage. A complete blockage stops urine flow, quickly raises pressure, and can become a medical emergency, especially if the urine above the stone gets infected.
In the realm of regenerative medicine and cellular research, the focus on ureteral stones extends to the sequelae of obstruction. When a ureter is obstructed, the renal parenchyma (the functional tissue of the kidney) undergoes metabolic stress. The nephrons, the filtration units, experience oxidative stress and inflammatory signaling. Prolonged obstruction can lead to tubular atrophy and interstitial fibrosis—permanent scarring of the kidney tissue.
Current research investigates the cellular resilience of the urinary tract. The ureteral smooth muscle cells undergo hypertrophy in the acute phase to increase peristaltic force. If the obstruction becomes chronic, these cells may undergo phenotypic changes or apoptosis (programmed cell death), leading to a non-functional, dilated ureter (hydroureter). The regenerative capacity of the kidney is remarkable; providing the obstruction is relieved within a critical window, renal function often recovers completely. However, the study of molecular markers for kidney injury (such as KIM-1 or NGAL) is advancing to determine better determine the point at which reversible damage becomes irreversible, guiding the urgency of intervention.
Furthermore, the urothelium—the specialized lining of the urinary tract—possesses significant regenerative properties. After the passage of a jagged crystal or following endoscopic instrumentation to remove a stone, the urothelium must repair the breach in the barrier. This healing process is mediated by urothelial stem cells and is crucial for preventing stricture formation (narrowing scar tissue) post-treatment. Thus, the management of ureteral stones is fundamentally an exercise in preserving the regenerative potential of the upper urinary tract.
Ureteral stones are becoming more common worldwide and are often linked to modern diets and lifestyles. They are especially frequent in hot, dry regions known as ‘stone belts,’ where dehydration is common and increases the risk. Still, people of all ages and backgrounds can be affected.
The modern definition of the disease also encompasses the concept of chronicity. For many patients, a ureteral stone is not a singular event but a manifestation of a chronic systemic metabolic disorder. This perspective shifts the clinical definition from a surgical problem to a medical condition requiring lifelong management. It underscores the importance of a multidisciplinary approach involving urologists, nephrologists, and dietitians to alter the urinary environment and prevent the recurrence of crystalline aggregation.
Send us all your questions or requests, and our expert team will assist you.
A kidney stone (nephrolithiasis) is a stone that is located within the kidney itself, where it formed. A ureteral stone (ureterolithiasis) is a kidney stone that has moved out of the kidney and traveled into the ureter, the tube connecting the kidney to the bladder. The symptoms and urgency of treatment often differ significantly once the stone enters the ureter due to the blockage of urine flow.
The stone itself does not typically form in the ureter; it forms in the kidney over weeks, months, or even years. Once it drops into the ureter, the onset of symptoms is usually sudden. The stone does not grow significantly in the ureter, as the rapid flow of urine (or its absence due to a blockage) does not favor the slow deposition of minerals required for growth.
Most stones, such as those made of calcium, cannot dissolve. They must either pass spontaneously through the urinary tract or be removed. The exception is uric acid stones, which can sometimes be dissolved by medical therapy that alkalizes the urine (raises the pH), turning the solid stone back into a soluble liquid form.
The location (proximal, mid, or distal ureter) dictates the symptoms and the surgical approach. Stones closer to the kidney (proximal) may cause flank pain and are often treated with shockwave therapy or flexible ureteroscopy. Stones closer to the bladder (distal) cause bladder irritation symptoms and are highly accessible for rigid ureteroscopic removal.
While the pain is excruciating, the stone itself is rarely fatal. However, it can become life-threatening if it causes a complete blockage in a patient with only one kidney or if the blocked urine becomes infected. An infected, obstructed kidney (pyonephrosis) is a medical emergency that can lead to sepsis and requires immediate drainage.
Your Comparison List (you must select at least 2 packages)
